CinCor Pharma Inc. is on the Cruelty-Free Investing usage of animals list because they undertake pre-clinical studies on animals to examine the safety profile of their medications.
The company stated in the following report that they exploit animals for product testing.
“In May 2019, the Company entered into a license agreement (the Roche Agreement) with F. Hoffman-La Roche Ltd. and Hoffmann-La Roche Inc. (collectively, Roche), pursuant to which the Company obtained an exclusive, worldwide, royalty-bearing license under patents and specified know-how owned or controlled by Roche and covering certain specified small molecule aldosterone synthase inhibitors (the Roche Technology) to research and develop products containing such aldosterone synthase inhibitors (the Licensed Products) for any and all uses, including the treatment, prevention or diagnosis of any and all diseases and medical conditions in humans and animals.” (Page 84) Read the full document
CinCor Pharma, Inc. operates as a clinical-stage biopharmaceutical company. The Company develops novel therapeutics for the treatment of hypertension and other cardio-renal diseases. CinCor Pharma serves customers in the United States.
Company Website: https://www.cincor.com